Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

QIAGEN DNA Synthesis AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 143,987 Less Arrow 100,080 Less Arrow 78,460
Financial expenses 7,400 More Arrow 8,941 Less Arrow 4,961
Earnings before taxes -2,606 Less Arrow -39,609 Less Arrow -53,200
EBITDA 16,046 Less Arrow -19,815 Less Arrow -40,223
Total assets 150,992 More Arrow 168,562 Less Arrow 159,529
Current assets 73,944 More Arrow 86,552 More Arrow 89,847
Current liabilities 116,747 More Arrow 131,698 More Arrow 140,555
Equity capital 34,245 More Arrow 36,864 Less Arrow 18,974
- share capital 200 Equal arrow 200 Equal arrow 200
Employees (average) 90 More Arrow 99 More Arrow 105

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 22.7% Less Arrow 21.9% Less Arrow 11.9%
Turnover per employee 1,600 Less Arrow 1,011 Less Arrow 747
Profit as a percentage of turnover -1.8% Less Arrow -39.6% Less Arrow -67.8%
Return on assets (ROA) 3.2% Less Arrow -18.2% Less Arrow -30.2%
Current ratio 63.3% More Arrow 65.7% Less Arrow 63.9%
Return on equity (ROE) -7.6% Less Arrow -107.4% Less Arrow -280.4%
Change turnover 43,907 Less Arrow 21,620 Less Arrow -7,087
Change turnover % 44% Less Arrow 28% Less Arrow -8%
Chg. No. of employees -9 More Arrow -6 More Arrow 8
Chg. No. of employees % -9% More Arrow -6% More Arrow 8%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.